JPMorgan cuts growth forecasts 'perilously close' to recession

JPMorgan cuts growth forecasts 'perilously close' to recession
The reduced its estimate for annualized gross domestic product growth to 1% for the second quarter, down from 2.5% previously.
JUL 05, 2022

JPMorgan Chase & Co. (JPM) economists cut their U.S. midyear economic growth forecasts after an influx of weaker data this week — most notably a slowdown in consumer spending.

The Wall Street bank reduced its estimate for annualized gross domestic product growth to 1% for the second quarter, down from 2.5% previously. This quarter is also seen at 1%, down from 2%. Growth will tick up to 1.5% in the final three months of the year, helped by stronger car production and lower inflation, the bank’s economists said.

“Our forecast comes perilously close to a recession,” Michael Feroli, JPMorgan’s chief U.S. economist, wrote in a note Friday. “However, we continue to look for the economy to expand, in part because we think employers may be reluctant to shed workers, even in a period of soft product demand.”

Odds of a recession in the U.S. have increased among Wall Street analysts in recent weeks as the Federal Reserve raises interest rates and decades-high inflation eats into consumers’ budgets. But most anticipate a downturn wouldn’t start until next year — if it does.

The Federal Reserve Bank of Atlanta Friday lowered its tracking estimate of U.S. GDP for the second quarter to a contraction of 2.1%, down from a 1% decline in its previous figure on June 30.

The Atlanta Fed tracking model, known as GDPNow, can be volatile and is designed to give a solid estimate just before each initial reading of GDP. While it’s often been more accurate than Wall Street consensus estimates, it’s been less reliable in the past two years as Covid-19 has changed economic patterns in sometimes unpredictable ways.

Covid has heightened attention to long-term care risk

Latest News

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

Investors accuse Netcapital of inflating revenue through sham deals
Investors accuse Netcapital of inflating revenue through sham deals

Sham agreements allegedly padded revenue by 345%.

Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli
Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli

"Most pre-retirees are uncomfortable making key retirement income decisions without an advisor's help," said Chris Bailey of Cerulli.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor